Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
As two iconic U.S. food brands, Krispy Kreme and McDonald’s attract very different types of investors. This article b...
Oil hovers near $70 a barrel as U.S.-Iran tensions flare, signaling a risk premium for energy and a wait-and-see stan...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...
When insiders trade shares, investors often wonder what it means for the stock. This guide breaks down the latest LeM...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
Digital Turbine APPS reported Q1 2026 results that highlighted continued monetization momentum and strategic partners...
The Pentagon says commercial data was used to target U.S. service members, a development that could spur tighter data...
A leaked document outlines a SpaceX strategy to move AI compute to orbit, potentially reshaping investment bets acros...
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
Redwire shares have tumbled, leaving investors wondering if the decline is temporary or a warning. This guide explain...